Home Featured Page 141

Featured

Latest

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

Eyes on Oregon: Special Edition

MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial...

Opinions | The Facts on Colorado Proposition 122

PT370 – Prohibition, Civil Disobedience, and The Coca Leaf Cafe

Webinar – The Dark Side of Psychedelic Therapies

Psychedelic Bulletin #122: Lusaris Raises $60m to Develop 5-MeO-DMT; First Take-Home...

COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights

Psychedelic Research Bulletin: October 2022

BREAKING: COMPASS Pathways Phase 2b Psilocybin Trial Published in NEJM

Considering a Career in Psychedelics? Here’s How to Get Started.

EDITOR PICKS

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

ShroomskiCon 2026

Eyes on Oregon: Special Edition

MindMed to Host Earnings Call to Discuss Third Quarter 2022 Financial...

Opinions | The Facts on Colorado Proposition 122

PT370 – Prohibition, Civil Disobedience, and The Coca Leaf Cafe

Webinar – The Dark Side of Psychedelic Therapies

Psychedelic Bulletin #122: Lusaris Raises $60m to Develop 5-MeO-DMT; First Take-Home...

COMPASS Pathways Announces Third Quarter 2022 Financial Results and Business Highlights

Psychedelic Research Bulletin: October 2022

BREAKING: COMPASS Pathways Phase 2b Psilocybin Trial Published in NEJM

Considering a Career in Psychedelics? Here’s How to Get Started.

EDITOR PICKS

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY